These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23290398)

  • 1. [Repairing rhythms in the brain of Alzheimer's mouse models].
    Verret L
    Med Sci (Paris); 2012 Dec; 28(12):1044-7. PubMed ID: 23290398
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cell-specific circadian clocks in metabolism and disease.
    Bray MS; Young ME
    Obes Rev; 2009 Nov; 10 Suppl 2():6-13. PubMed ID: 19849797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biology and genetics of circadian rhythm].
    Bellivier F
    Encephale; 2009 Jan; 35 Suppl 2():S53-7. PubMed ID: 19268171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease.
    Dorr A; Sahota B; Chinta LV; Brown ME; Lai AY; Ma K; Hawkes CA; McLaurin J; Stefanovic B
    Brain; 2012 Oct; 135(Pt 10):3039-50. PubMed ID: 23065792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
    Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
    Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circadian system in Alzheimer's disease: disturbances, mechanisms, and opportunities.
    Coogan AN; Schutová B; Husung S; Furczyk K; Baune BT; Kropp P; Häßler F; Thome J
    Biol Psychiatry; 2013 Sep; 74(5):333-9. PubMed ID: 23273723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the blood-brain barrier in Alzheimer's disease].
    Gosselet F; Candela P; Cecchelli R; Fenart L
    Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional plasticity of the circadian timing system in old age: light exposure.
    Van Someren EJ; Riemersma RF; Swaab DF
    Prog Brain Res; 2002; 138():205-31. PubMed ID: 12432772
    [No Abstract]   [Full Text] [Related]  

  • 10. Restless nights, listless days.
    Abbott A
    Nature; 2003 Oct; 425(6961):896-8. PubMed ID: 14586438
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R; Dyck RH; Laferla FM; Antle MC
    Brain Res; 2010 Aug; 1348():139-48. PubMed ID: 20471965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sink hypothesis and therapeutic strategies for attenuating Abeta levels.
    Zhang Y; Lee DH
    Neuroscientist; 2011 Apr; 17(2):163-73. PubMed ID: 21330304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
    Fabbro S; Schaller K; Seeds NW
    J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice.
    Ambrée O; Touma C; Görtz N; Keyvani K; Paulus W; Palme R; Sachser N
    Neurobiol Aging; 2006 Jul; 27(7):955-64. PubMed ID: 15993515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shift and night work from the point of view of occupational health].
    Rüdiger HW
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2451-2. PubMed ID: 17066352
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease.
    Wang J; Ho L; Qin W; Rocher AB; Seror I; Humala N; Maniar K; Dolios G; Wang R; Hof PR; Pasinetti GM
    FASEB J; 2005 Apr; 19(6):659-61. PubMed ID: 15650008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
    Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
    J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronomics complement, among many other fields, genomics and proteomics.
    Halberg F; Cornélissen G; Katinas G; Hillman D; Schwartzkopff O;
    Neuro Endocrinol Lett; 2001; 22(1):53-73. PubMed ID: 11393163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.